|1.||Verma, Anita K: 1 article (04/2005)|
|2.||Tyagi, Richa: 1 article (04/2005)|
|3.||Nandy, A K: 1 article (04/2005)|
|4.||Mahato, Shashi Bhushan: 1 article (04/2005)|
|5.||Maitra, Amarnath: 1 article (04/2005)|
|6.||Basu, Mukul Kumar: 1 article (04/2005)|
|7.||Lala, Sanchaita: 1 article (04/2005)|
04/01/2005 - "Targeted delivery of arjunglucoside I using surface hydrophilic and hydrophobic nanocarriers to combat experimental leishmaniasis."
04/01/2005 - "The purpose of the present study was to investigate the therapeutic efficacy of the indigenous drug arjunglucoside I (AG) against in vivo models of experimental leishmaniasis by incorporating it in surface hydrophilic co-polymeric nanogel particles of size less than 100 nm diameter and to compare its efficacy with that of the free drug as well as the drug encapsulated in hydrophobic poly-dl-lactide (PLA) nanoparticles. "